Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus

Chao Ma and Hongjuan Liu
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1440;
Chao Ma
1Nuclear Medicine Affiliated Xinhua Hospital School of Medicine Shanghai Jiaotong University Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongjuan Liu
2Nuclear Medicine of Bone and Joint Henan Luoyang Zhenggu Hospital and Henan Orthopedics Hospital Luoyang China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1440

Objectives To investigate the effects of 99Tc-MDP (Yunke) treatment on Oosteochondral lesion of talus (OCLT)

Methods In the clinical evaluation, 66 patients were retrospectively included and treated with a combination of 99Tc-MDP and Chinese herbal fumigation (CHF) for symptomatic OCLT. They were evaluated by the American Orthopedic Foot and Ankle Society Ankle-Hindfoot Score (AOFAS), visual analog scale (VAS), activities of daily living (Barthel index), and MRI, 99mTc-MDP SPECT/CT. Radiographic changes were also assessed by the transverse long diameter of the cyst on CT.

Results A total of 83 lesions of OCLT who failed appropriate nonoperative treatment and surgery were included. At the last follow up, AOFAS, VAS and Barthel index improved significantly from 68.66±9.76, 3.05±0.34 and 85±8.31 to 85.4±8.31, 1.85±0.36 and 94.7±4.99 (p<0.01), respectively after one course treatment in 66 patients with OCLT. Thirty one (31/66) patients had two courses treatment with 99Tc-MDP and CHF. Their AOFAS, VAS and Barthel index also improved significantly after the mean follow-up of 7 ±2 (6-15) months. And the average diameter of the cysts decreased from 8.01 ± 3.35 mm to 4.74± 2.83mm (p<0.01) in the 31 patients.

Conclusions Pain relief and return of function and decreased cystic lesions were obtained after a combination treatment of 99Tc-MDP and CHF for patients with OCLT. Our results suggest that the small cystic lesions with increased uptake of 99mTc-MDP on SPECT/CT can be well treated by 99Tc-MDP and CHF. This novel technique holds the potential to emerge as an effective conservative treatment for OCLT without adverse effects.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus
Chao Ma, Hongjuan Liu
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1440;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus
Chao Ma, Hongjuan Liu
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1440;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Radiopharmaceutical Therapy Posters

  • Monitoring radioiodine-induced apoptotic and autophagic cell death in mouse colon cancer model
  • Ac-225-PSMA617 - a single center experience of 40 patients receiving PSMA-targeted Alpha therapy
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire